Ranbaxy introduces Absorica in US
Could become largest selling product in US by 2014
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Mylan to supply ARVs to South African National Department of Health
Company secured 19.1 per cent of R5.9 billion tender value for 2013
GSK, J&J, Sanofi top this year’s Access to Medicine Index
Report finds Big Pharma doing more for access to medicine in developing countries than two years ago
Lonza and Sartorius Stedim Biotech tie up
In a collaboration supply and distribution agreement in the field of Cell culture media
Lupin to launch Bayer generic tabs Yasmin
Lupin’s Drospirenone and Ethinyl Estradiol tablets are a combined oral contraceptive for women
Nov’ 12 pharma M&A dips in volume, stablises in value
Increasing product offerings, to accelerate growth opportunities, drives M&A activity in November, according to Datamonitor’s…
Pharmexcil to represent India Pavilion at Arab Health 2013 in Dubai
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is confident of India’s pharmaceutical industry’s growth…
CPhI India 2012 meet exhibitors’ expectations
Next year’s event to be held from December 3-5, 2013
ACTA Down, But what next?
The EU parliament has rejected the Anti-Countefeiting Trade Agreement (ACTA) but there are other similar moves to restrict free…
Moving with the market
Viveka Roychowdhury reports on the successful right sizing of strategies by both pharma MNCs and their Indian counterparts
Nurturing India’s small biotech
With India's DBT committing 30 per cent of its budget to PPPs, will these fund an ecosystem for small and medium sized companies…
Soaring High
Indian pharmaceutical companies in order mark its presence in the international markets, need to focus on regions having high…
Safer paths to greener pastures
With World Environment Day fast approaching, Usha Sharma analyses the pharma industry's measures to preserve the environment and…
Opportunities Galore for India’s Biotech Industry
India is an attractive destination for biotech enterpreneurs from across the globe and local companies are prising open this door…
M&A or MIA?
After witnessing watershed deals in the past few years, the M&A scenario in India seems to be MIA: Missing in Action. However,…
Beyond The Ban
The Government of India recently banned the use of serology-based test kits for diagnosis of tuberculosis. But this will translate…
CDSCO Draft Guidelines: Industry gives its verdict
Recently, the Central Drugs Standard Control Organisation (CDSCO) called for recommendations and suggestions on its draft…